Calcium and Zoledronic Acid, a synergy.
Zoledronic acid rapidly suppresses bone resorption and can drive serum calcium down within days of infusion, especially in patients with low calcium intake, vitamin D deficiency, or impaired renal function. Adequate calcium intake is required by major osteoporosis guidelines before and during zoledronate therapy.
One pair, every claim cited. The two substances, the type, the mechanism, the recommendation, and the primary literature.
Same shape as the other 1,729 pairs in the public database.
From the interaction database
What the row says.
Every entry follows the same shape: what is happening, the mechanism, the recommendation, and the primary literature.
At a glance
- Substances
- Calcium and Zoledronic Acid
- Pair type
- Synergy
- Evidence (highest tier)
- Strong
- Source citations
- 2 sources
- Stack Score effect
- +2 to your Stack Score (per scored synergy row).
- Scope
- Supplement × Prescription
- Last verified
- May 30, 2026
Synergy · Strong evidence
Synergy
What is happening. Zoledronic acid rapidly suppresses bone resorption and can drive serum calcium down within days of infusion, especially in patients with low calcium intake, vitamin D deficiency, or impaired renal function. Adequate calcium intake is required by major osteoporosis guidelines before and during zoledronate therapy.
Mechanism. Zoledronate inhibits osteoclast FPPS, halting bone resorption and the calcium efflux from bone that normally helps maintain serum calcium. Adequate dietary calcium supplies the system from the gut instead, preventing hypocalcemia.
Recommendation. Take elemental calcium 1000-1200 mg/day from diet plus supplements (split 500 mg per dose) throughout zoledronate therapy. Ensure intake is adequate in the days immediately after each infusion. Because zoledronate is given intravenously, there is no oral-dose timing concern.
Sources (2)
- Crotti C, Watts NB, De Santis M, et al. Acute Phase Reactions After Zoledronic Acid Infusion: Protective Role of 25-Hydroxyvitamin D and Previous Oral Bisphosphonate Therapy. Endocr Pract. 2018;24(5):405-410. PMID 29498910
- Wiesner A, Szuta M, Galanty A, Paśko P. Optimal Dosing Regimen of Osteoporosis Drugs in Relation to Food Intake as the Key for the Enhancement of the Treatment Effectiveness-A Concise Literature Review. Foods. 2021;10(4):720. PMID 33805435
Stack Score
How this pair moves the number.
Effect on the composite score
If both Calcium and Zoledronic Acid are in the same stack, this pair applies +2 to your Stack Score (per scored synergy row).
The full algorithm, the clamping rules, and four worked stacks are documented at /methodology/stack-score.
Check your full routine
One pair was the worked example. NutriStack runs every pair in your stack at once.
Drop in your supplements and prescriptions and the public database surfaces every interaction, synergy, timing rule, and contraindication, every one linked to its primary source.